SUPERNUS PHARMACEUTICALS, INC. Financing Cash Flow
SUPERNUS PHARMACEUTICALS, INC. (SUPN) reported Financing Cash Flow of $1.92 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-03
- SUPERNUS PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$7.20M, a 870.05% decline year-over-year.
- SUPERNUS PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $9.12M.
- SUPERNUS PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $8.53M, a 44.75% increase year-over-year.
- SUPERNUS PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $21.07M, a 585.14% increase year-over-year.
- SUPERNUS PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for fiscal 2025 was $9.13M, a 25.12% decline from fiscal 2024.
- SUPERNUS PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for fiscal 2024 was $12.19M.
- SUPERNUS PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for fiscal 2023 was -$397.88M.
- SUPERNUS PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for fiscal 2022 was -$10.48M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$7.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $1.92M 10-Q · filed 2026-08-03 | $10.44M derived: sum of 3 quarters · filed 2026-08-03 | $31.51M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2026-03-31 | $9.12M 10-Q · filed 2026-05-05 | $17.64M derived: sum of 2 quarters · filed 2026-05-05 | $38.71M derived: sum of 3 quarters · filed 2026-05-05 | $39.64M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2025-12-31 | $8.53M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $29.59M derived: sum of 2 quarters · filed 2026-03-02 | $30.53M derived: sum of 3 quarters · filed 2026-08-03 | $9.13M 10-K · filed 2026-03-02 | ||
| 2025-09-30 | $21.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $22.00M derived: sum of 2 quarters · filed 2026-08-03 | $604.00K 10-Q · filed 2025-11-06 | $6.49M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2025-06-30 | $935.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | -$20.46M 10-Q · filed 2026-08-03 | -$14.57M derived: sum of 3 quarters · filed 2026-08-03 | -$11.50M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2025-03-31 | -$21.40M 10-Q · filed 2026-05-05 | -$15.51M derived: sum of 2 quarters · filed 2026-05-05 | -$12.43M derived: sum of 3 quarters · filed 2026-05-05 | -$10.78M derived: sum of 4 quarters · filed 2026-05-05 | ||
| 2024-12-31 | $5.89M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $8.96M derived: sum of 2 quarters · filed 2026-03-02 | $10.62M derived: sum of 3 quarters · filed 2026-03-02 | $12.19M 10-K · filed 2026-03-02 | ||
| 2024-09-30 | $3.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $4.73M derived: sum of 2 quarters · filed 2025-11-06 | $6.30M 10-Q · filed 2025-11-06 | $7.39M derived: sum of 4 quarters · filed 2026-03-02 | ||
| 2024-06-30 | $1.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $3.23M 10-Q · filed 2025-08-05 | $4.32M derived: sum of 3 quarters · filed 2026-03-02 | $4.09M derived: sum of 4 quarters · filed 2026-03-02 | ||
| 2024-03-31 | $1.57M 10-Q · filed 2025-05-06 | $2.66M derived: sum of 2 quarters · filed 2026-03-02 | $2.43M derived: sum of 3 quarters · filed 2026-03-02 | -$476.48M derived: sum of 4 quarters · filed 2026-03-02 | ||
| 2023-12-31 | $1.09M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $862.00K derived: sum of 2 quarters · filed 2026-03-02 | -$478.05M derived: sum of 3 quarters · filed 2026-03-02 | -$397.88M 10-K · filed 2026-03-02 | ||
| 2023-09-30 | -$230.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | -$479.15M derived: sum of 2 quarters · filed 2024-11-04 | -$398.97M 10-Q · filed 2024-11-04 | -$396.14M derived: sum of 4 quarters · filed 2025-02-25 | ||
| 2023-06-30 | -$478.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$398.74M 10-Q · filed 2024-08-06 | -$395.91M derived: sum of 3 quarters · filed 2025-02-25 | -$389.46M derived: sum of 4 quarters · filed 2025-02-25 | ||
| 2023-03-31 | $80.17M 10-Q · filed 2024-05-08 | $83.00M derived: sum of 2 quarters · filed 2025-02-25 | $89.46M derived: sum of 3 quarters · filed 2025-02-25 | $91.73M derived: sum of 4 quarters · filed 2025-02-25 | ||
| 2022-12-31 | $2.83M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $9.28M derived: sum of 2 quarters · filed 2025-02-25 | $11.56M derived: sum of 3 quarters · filed 2025-02-25 | -$10.48M 10-K · filed 2025-02-25 | ||
| 2022-09-30 | $6.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $8.73M derived: sum of 2 quarters · filed 2023-11-08 | -$13.31M 10-Q · filed 2023-11-08 | -$150.05M derived: sum of 4 quarters · filed 2023-11-08 | ||
| 2022-06-30 | $2.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$19.76M 10-Q · filed 2023-08-08 | -$156.50M derived: sum of 3 quarters · filed 2023-08-08 | -$155.18M derived: sum of 4 quarters · filed 2023-08-08 | ||
| 2022-03-31 | -$22.03M 10-Q · filed 2023-05-09 | -$158.77M derived: sum of 2 quarters · filed 2023-05-09 | -$157.45M derived: sum of 3 quarters · filed 2023-05-09 | -$154.70M derived: sum of 4 quarters · filed 2023-05-09 | ||
| 2021-12-31 | -$136.74M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | -$135.42M derived: sum of 2 quarters · filed 2023-03-09 | -$132.67M derived: sum of 3 quarters · filed 2023-03-09 | -$130.42M 10-K · filed 2023-03-09 | ||
| 2021-09-30 | $1.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $4.07M derived: sum of 2 quarters · filed 2022-11-09 | $6.32M 10-Q · filed 2022-11-09 | $9.39M derived: sum of 4 quarters · filed 2023-03-09 | ||
| 2021-06-30 | $2.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $5.00M 10-Q · filed 2022-08-08 | $8.06M derived: sum of 3 quarters · filed 2023-03-09 | $7.09M derived: sum of 4 quarters · filed 2023-03-09 | ||
| 2021-03-31 | $2.25M 10-Q · filed 2022-05-12 | $5.32M derived: sum of 2 quarters · filed 2023-03-09 | $4.34M derived: sum of 3 quarters · filed 2023-03-09 | $5.77M derived: sum of 4 quarters · filed 2023-03-09 | ||
| 2020-12-31 | $3.07M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $2.09M derived: sum of 2 quarters · filed 2023-03-09 | $3.53M derived: sum of 3 quarters · filed 2023-03-09 | $3.56M 10-K · filed 2023-03-09 | ||
| 2020-09-30 | -$979.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $458.00K derived: sum of 2 quarters · filed 2021-11-05 | $490.00K 10-Q · filed 2021-11-05 | $1.75M derived: sum of 4 quarters · filed 2022-04-13 | ||
| 2020-06-30 | $1.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $1.47M 10-Q · filed 2021-08-06 | $2.73M derived: sum of 3 quarters · filed 2022-04-13 | $2.97M derived: sum of 4 quarters · filed 2022-04-13 | ||
| 2020-03-31 | $32.00K 10-Q · filed 2021-05-07 | $1.29M derived: sum of 2 quarters · filed 2022-04-13 | $1.54M derived: sum of 3 quarters · filed 2022-04-13 | $3.18M derived: sum of 4 quarters · filed 2022-04-13 | ||
| 2019-12-31 | $1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-13 | $1.50M derived: sum of 2 quarters · filed 2022-04-13 | $3.15M derived: sum of 3 quarters · filed 2022-04-13 | $3.93M 10-K · filed 2022-04-13 | ||
| 2019-09-30 | $242.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $1.88M derived: sum of 2 quarters · filed 2020-11-06 | $2.67M 10-Q · filed 2020-11-06 | $3.92M derived: sum of 4 quarters · filed 2021-03-08 | ||
| 2019-06-30 | $1.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-17 | $2.42M 10-Q · filed 2020-08-17 | $3.67M derived: sum of 3 quarters · filed 2021-03-08 | $4.50M derived: sum of 4 quarters · filed 2021-03-08 | ||
| 2019-03-31 | $783.00K 10-Q · filed 2020-05-15 | $2.03M derived: sum of 2 quarters · filed 2021-03-08 | $2.86M derived: sum of 3 quarters · filed 2021-03-08 | $9.51M derived: sum of 4 quarters · filed 2021-03-08 | ||
| 2018-12-31 | $1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08 | $2.08M derived: sum of 2 quarters · filed 2021-03-08 | $8.72M derived: sum of 3 quarters · filed 2021-03-08 | $376.44M 10-K · filed 2021-03-08 | ||
| 2018-09-30 | $828.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $7.47M derived: sum of 2 quarters · filed 2019-11-08 | $375.19M 10-Q · filed 2019-11-08 | $376.36M derived: sum of 4 quarters · filed 2020-02-28 | ||
| 2018-06-30 | $6.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $374.36M 10-Q · filed 2019-08-09 | $375.53M derived: sum of 3 quarters · filed 2020-02-28 | $377.88M derived: sum of 4 quarters · filed 2020-02-28 | ||
| 2018-03-31 | $367.71M 10-Q · filed 2019-05-10 | $368.88M derived: sum of 2 quarters · filed 2020-02-28 | $371.23M derived: sum of 3 quarters · filed 2020-02-28 | $372.79M derived: sum of 4 quarters · filed 2020-02-28 | ||
| 2017-12-31 | $1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $3.52M derived: sum of 2 quarters · filed 2020-02-28 | $5.08M derived: sum of 3 quarters · filed 2020-02-28 | $5.68M 10-K · filed 2020-02-28 | ||
| 2017-09-30 | $2.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $3.91M derived: sum of 2 quarters · filed 2018-11-09 | $4.51M 10-Q · filed 2018-11-09 | $5.31M derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2017-06-30 | $1.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $2.16M 10-Q · filed 2018-08-09 | $2.96M derived: sum of 3 quarters · filed 2019-03-01 | $3.22M derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2017-03-31 | $604.00K 10-Q · filed 2018-05-10 | $1.40M derived: sum of 2 quarters · filed 2019-03-01 | $1.66M derived: sum of 3 quarters · filed 2019-03-01 | |||
| 2016-12-31 | $797.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $1.06M derived: sum of 2 quarters · filed 2019-03-01 | $2.05M 10-K · filed 2019-03-01 | |||
| 2016-09-30 | $260.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $1.25M 10-Q · filed 2017-11-09 | ||||
| 2016-06-30 | $995.00K 10-Q · filed 2017-08-03 | |||||
| 2015-12-31 | $800.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2018-03-01 | $858.00K derived: sum of 2 quarters · filed 2018-03-01 | $1.72M derived: sum of 3 quarters · filed 2018-03-01 | $1.87M 10-K · filed 2018-03-01 | ||
| 2015-09-30 | $58.00K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2017-01-20 | $920.00K derived: sum of 2 quarters · filed 2017-01-20 | $1.07M 10-Q/A · filed 2017-01-20 | $1.37M derived: sum of 4 quarters · filed 2017-01-20 | ||
| 2015-06-30 | $862.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $1.01M 10-Q · filed 2015-08-07 | $1.31M derived: sum of 3 quarters · filed 2017-01-20 | $31.33M derived: sum of 4 quarters · filed 2017-01-20 | ||
| 2015-03-31 | $147.00K 10-Q · filed 2015-05-06 | $453.00K derived: sum of 2 quarters · filed 2017-01-20 | $30.47M derived: sum of 3 quarters · filed 2017-01-20 | $30.71M derived: sum of 4 quarters · filed 2017-01-20 | ||
| 2014-12-31 | $306.00K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2017-01-20 | $30.32M derived: sum of 2 quarters · filed 2017-01-20 | $30.57M derived: sum of 3 quarters · filed 2017-01-20 | $30.57M 10-K/A · filed 2017-01-20 | $570.00K 10-K · filed 2015-03-12 | |
| 2014-09-30 | $30.01M derived: 10-Q/A 9 month − 10-Q 6 month · filed 2017-01-20 | $30.26M derived: sum of 2 quarters · filed 2017-01-20 | $30.26M 10-Q/A · filed 2017-01-20 | $264.00K 10-Q · filed 2014-11-12 | $28.81M derived: sum of 4 quarters · filed 2017-01-20 | |
| 2014-06-30 | $245.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $250.00K 10-Q · filed 2015-08-07 | -$1.20M derived: sum of 3 quarters · filed 2017-01-20 | -$1.22M derived: sum of 4 quarters · filed 2017-01-20 | ||
| 2014-03-31 | $5.00K 10-Q · filed 2015-05-06 | -$1.45M derived: sum of 2 quarters · filed 2017-01-20 | -$1.47M derived: sum of 3 quarters · filed 2017-01-20 | $63.77M derived: sum of 4 quarters · filed 2017-01-20 | ||
| 2013-12-31 | -$1.45M derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-01-20 | -$1.47M derived: sum of 2 quarters · filed 2017-01-20 | $63.76M derived: sum of 3 quarters · filed 2017-01-20 | $62.74M 10-K/A · filed 2017-01-20 | ||
| 2013-09-30 | -$18.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $65.21M derived: sum of 2 quarters · filed 2014-11-12 | $64.19M 10-Q · filed 2014-11-12 | $106.57M derived: sum of 4 quarters · filed 2015-03-12 | ||
| 2013-06-30 | $65.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | $64.21M 10-Q · filed 2014-08-12 | $106.59M derived: sum of 3 quarters · filed 2015-03-12 | $104.36M derived: sum of 4 quarters · filed 2015-03-12 | ||
| 2013-03-31 | -$1.02M 10-Q · filed 2014-05-13 | $41.35M derived: sum of 2 quarters · filed 2015-03-12 | $39.13M derived: sum of 3 quarters · filed 2015-03-12 | $87.95M derived: sum of 4 quarters · filed 2015-03-12 | ||
| 2012-12-31 | $42.38M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $40.15M derived: sum of 2 quarters · filed 2015-03-12 | $88.97M derived: sum of 3 quarters · filed 2015-03-12 | $87.92M 10-K · filed 2015-03-12 | ||
| 2012-09-30 | -$2.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | $46.60M derived: sum of 2 quarters · filed 2013-11-13 | $45.54M 10-Q · filed 2013-11-13 | $60.43M derived: sum of 4 quarters · filed 2014-03-21 | ||
| 2012-06-30 | $48.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $47.77M 10-Q · filed 2013-08-14 | $62.65M derived: sum of 3 quarters · filed 2014-03-21 | $61.34M derived: sum of 4 quarters · filed 2014-03-21 | ||
| 2012-03-31 | -$1.06M 10-Q · filed 2013-05-15 | $13.83M derived: sum of 2 quarters · filed 2014-03-21 | $12.51M derived: sum of 3 quarters · filed 2014-03-21 | $13.43M derived: sum of 4 quarters · filed 2014-03-21 | ||
| 2011-12-31 | $14.89M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-21 | $13.57M derived: sum of 2 quarters · filed 2014-03-21 | $14.48M derived: sum of 3 quarters · filed 2014-03-21 | $27.09M 10-K · filed 2014-03-21 | ||
| 2011-09-30 | -$1.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | -$405.00K derived: sum of 2 quarters · filed 2012-11-02 | $12.20M 10-Q · filed 2012-11-02 | |||
| 2011-06-30 | $912.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-13 | $13.52M 10-Q · filed 2012-08-13 | ||||
| 2011-03-31 | $12.61M 10-Q · filed 2012-06-08 | |||||
| 2010-12-31 | -$944.00K 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |